Overview

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Status:
Completed

Trial end date:
2016-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the efficacy and tolerability between clopidogrel resinate and clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD equivalents.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Hospital

Collaborator:

CKD Pharmaceutical Limited

Treatments:

Aspirin
Clopidogrel
Ticlopidine